The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are

Attend this free event hosted by The Conference Forum to hear from NIH technology transfer expert, Steve Ferguson, on why NIH is a premier technology development and commercialization partner. Ferguson is a Special Advisor at OTT and brings 30+ years of experience on how to set up successful

Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for a drug-like, patent-protected platform ready for lead optimization or IND-enabling studies in lung, liver and cardiac fibrosis, pulmonary arterial hypertension